| 96374 | The provider administers a single medication or other substance rapidly into a vein to treat, prevent, or diagnose a condition. | 62 | 60 | 3,620 | $90 | $623.7K |
| Q5103 | Injection, infliximab-dyyb, biosimilar, (inflectra), 10 mg | 4 | 10 | 100 | $1,160 | $435.3K |
| J0585 | Injection, onabotulinumtoxina, 1 unit | 7 | 20 | 470 | $460 | $398.7K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 22 | 1,500 | 650 | $70 | $312.4K |
| 97530 | The provider uses various activities during direct contact with the patient to improve the patient’s functional performance. Use this code for each 15 minutes of activity. | 32 | 290 | 770 | $60 | $252K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 20 | 1,590 | 590 | $50 | $236.5K |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | 2 | 10 | 30 | $2,290 | $236.2K |
| 76811 | The provider performs an ultrasound study using a transabdominal approach to examine the fetus and mother, along with additional examination of the fetal anatomy, such as the heart rate, amniotic… | 17 | 20 | 310 | $140 | $234.4K |
| 76816 | The provider reexamines the fetus to follow up on a prior abnormal transabdominal ultrasound. | 39 | 50 | 60 | $80 | $170.1K |
| 77067 | The provider takes two X–ray views of each breast for routine screening and may use specially designed computer software to help identify any potential abnormalities within the images; the software… | 26 | 70 | 690 | $50 | $169.3K |